These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 10477187)

  • 1. Expression of hydrophilic surface proteins in infective stages of Leishmania donovani.
    Alce TM; Gokool S; McGhie D; Stäger S; Smith DF
    Mol Biochem Parasitol; 1999 Jul; 102(1):191-6. PubMed ID: 10477187
    [No Abstract]   [Full Text] [Related]  

  • 2. Identification of new antigens in visceral leishmaniasis by expression cloning and immunoblotting with sera of kala-azar patients from Bihar, India.
    Theinert SM; Basu R; Forgber M; Roy S; Sundar S; Walden P
    Infect Immun; 2005 Oct; 73(10):7018-21. PubMed ID: 16177384
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serodiagnostic and immunoprophylactic potential of a 78kDa protein of Leishmania donovani of Indian origin.
    Mukherjee M; Bhattacharyya A; Duttagupta S
    Med Sci Monit; 2002 Apr; 8(4):BR117-22. PubMed ID: 11951057
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunization with a recombinant stage-regulated surface protein from Leishmania donovani induces protection against visceral leishmaniasis.
    Stäger S; Smith DF; Kaye PM
    J Immunol; 2000 Dec; 165(12):7064-71. PubMed ID: 11120835
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Short report: production of recombinant kinesin-related protein of Leishmania donovani and its application in the serodiagnosis of visceral leishmaniasis.
    Takagi H; Islam MZ; Itoh M; Islam AU; Saifuddin Ekram AR; Hussain SM; Hashiguchi Y; Kimura E
    Am J Trop Med Hyg; 2007 May; 76(5):902-5. PubMed ID: 17488913
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fluorescent antibody titres after recovery from visceral leishmaniasis.
    Basu D; Mallik KK; Bhattacharya A; Ghosh AK
    Acta Trop; 1991 Nov; 50(1):87-8. PubMed ID: 1723840
    [No Abstract]   [Full Text] [Related]  

  • 7. Generation and evaluation of A2-expressing Lactococcus lactis live vaccines against Leishmania donovani in BALB/c mice.
    Yam KK; Hugentobler F; Pouliot P; Stern AM; Lalande JD; Matlashewski G; Olivier M; Cousineau B
    J Med Microbiol; 2011 Sep; 60(Pt 9):1248-1260. PubMed ID: 21527547
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunization with A2 protein results in a mixed Th1/Th2 and a humoral response which protects mice against Leishmania donovani infections.
    Ghosh A; Zhang WW; Matlashewski G
    Vaccine; 2001 Oct; 20(1-2):59-66. PubMed ID: 11567746
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vaccination with DNA encoding ORFF antigen confers protective immunity in mice infected with Leishmania donovani.
    Sukumaran B; Tewary P; Saxena S; Madhubala R
    Vaccine; 2003 Mar; 21(11-12):1292-9. PubMed ID: 12559811
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Leucine rich repeats are the main epitopes in Leishmania infantum PSA during canine and human visceral leishmaniasis.
    Boceta C; Alonso C; Jiménez-Ruiz A
    Parasite Immunol; 2000 Feb; 22(2):55-62. PubMed ID: 10652117
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunization with recombinant LD1 antigens protects against experimental leishmaniasis.
    Dole VS; Raj VS; Ghosh A; Madhubala R; Myler PJ; Stuart KD
    Vaccine; 2000 Oct; 19(4-5):423-30. PubMed ID: 11027804
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparative assessment of a DNA and protein Leishmania donovani gamma glutamyl cysteine synthetase vaccine to cross-protect against murine cutaneous leishmaniasis caused by L. major or L. mexicana infection.
    Campbell SA; Alawa J; Doro B; Henriquez FL; Roberts CW; Nok A; Alawa CB; Alsaadi M; Mullen AB; Carter KC
    Vaccine; 2012 Feb; 30(7):1357-63. PubMed ID: 22210224
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prophylactic immunization against experimental Leishmania donovani infection by use of a purified protein vaccine.
    White AC; McMahon-Pratt D
    J Infect Dis; 1990 Jun; 161(6):1313-4. PubMed ID: 2345310
    [No Abstract]   [Full Text] [Related]  

  • 14. Patients infected with Leishmania donovani chagasi can have antibodies that recognize heat shock and acidic ribosomal proteins of Trypanosoma cruzi.
    Nafziger DA; Recinos RF; Hunter CA; Donelson JE
    Mol Biochem Parasitol; 1991 Dec; 49(2):325-8. PubMed ID: 1723150
    [No Abstract]   [Full Text] [Related]  

  • 15. Molecular characterization of a kinesin-related antigen of Leishmania chagasi that detects specific antibody in African and American visceral leishmaniasis.
    Burns JM; Shreffler WG; Benson DR; Ghalib HW; Badaro R; Reed SG
    Proc Natl Acad Sci U S A; 1993 Jan; 90(2):775-9. PubMed ID: 8421715
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Leishmania donovani p36(LACK) DNA vaccine is highly immunogenic but not protective against experimental visceral leishmaniasis.
    Melby PC; Yang J; Zhao W; Perez LE; Cheng J
    Infect Immun; 2001 Aug; 69(8):4719-25. PubMed ID: 11447143
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression of a repeating phosphorylated disaccharide lipophosphoglycan epitope on the surface of macrophages infected with Leishmania donovani.
    Tolson DL; Turco SJ; Pearson TW
    Infect Immun; 1990 Nov; 58(11):3500-7. PubMed ID: 1699895
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Specific serodiagnosis of visceral leishmaniasis using a Leishmania donovani antigen identified by expression cloning.
    Blaxter ML; Miles MA; Kelly JM
    Mol Biochem Parasitol; 1988 Sep; 30(3):259-70. PubMed ID: 2972929
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Human visceral leishmaniasis: analysis of the specificity of humoral immune response to polypeptides of Leishmania donovani chagasi.
    dos Santos JI; Morgado MG; Galvão-Castro B
    Am J Trop Med Hyg; 1987 Sep; 37(2):263-70. PubMed ID: 2444121
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Studies on the protective efficacy of freeze thawed promastigote antigen of Leishmania donovani along with various adjuvants against visceral leishmaniasis infection in mice.
    Thakur A; Kaur H; Kaur S
    Immunobiology; 2015 Sep; 220(9):1031-8. PubMed ID: 26001730
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.